Research
Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance
Published on: 22 August 2017
Articles
-
-
Research
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics
Published on: 15 August 2017
-
Research
Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma
Published on: 15 August 2017
-
Research
-
Commentary
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Published on: 8 August 2017
-
Research
-
Research
Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal stem cell therapy
Published on: 31 May 2013
The Erratum to this article has been published in Journal of Translational Medicine 2014 12:269
-
Review
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
Published on: 14 November 2012
-
Review
-
Review
Influence of diet on the gut microbiome and implications for human health
Published on: 8 April 2017
Editor-in-Chief
Francesco Marincola, AbbVie Biotherapeutics Corporation, USA
Featured series: Hot topics
The Journal of Translational Medicine is excited to launch the Hot Topics series, which will publish a limited number of high interest review articles per year, focussing on cutting edge topics from across the breadth of the journal’s scope. Articles will cover emerging concepts and points of view or foresights, rather than focusing on comprehensive discussions of well-established areas. We encourage the participation of investigators from different groups with complementary expertise in the proposed theme.
Articles should be submitted by invitation of Editor-in-Chief, Francesco Marincola, only, and will be published in the series free of charge. If you would like to propose a review article for the Hot Topics series, please contact Dr Marincola at jtransmed@biomedcentral.com with a suggested outline.
Aims and scope
Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science.
The journal covers all areas of translational medicine but also has several special sections:
- Cancer microenvironment - Edited by Davide Bedognetti
- Cardiovascular, Metabolic and Lipoprotein Translation - Edited by Nehal N. Mehta
- Cell, tissue and gene therapy - Edited by David Stroncek
- Clinical translation - Edited by Lana Kandalaft
- Combination strategies - Edited by Paolo A. Ascierto
- Computational modelling and Epidemiology- Edited by Michael Liebman and Sabrina Molinaro
- Disease biomarkers - Edited by Xiangdong Wang
- Immunobiology and immunotherapy - Edited by Adrian Bot
- Immunovirology - Edited by Luigi Buonaguro
- Medical Bioinformatics - Edited by Samir K. Brahmachari
- Neuroscience - Edited by Luis F. Alguacil
- Nutrition & metabolism - Edited by Laura Soldati
- Pain, Critical Care and Anesthesia - Edited by Yasin S. Al Makadma
- Patient-targeted molecular therapies - Edited by Francesco Chiappelli and Francesco Piva
- Personalized medicine - Edited by Lotfi Chouchane
- Translational Imaging - Edited by Ravinder Reddy
- Translational hematology- Edited by Seah H. Lim
Featured Section
Translational hematology- Section edited by Seah H. Lim
This section will provide an international platform for presentation of high quality clinical and laboratory translational research, bridging the gap between basic research and pure clinical studies. The scope includes clinical and clinico-pathological investigations and fundamental research of translational potential in hematologic diseases. These include studies in red blood cells, white blood cells, platelets, coagulation, transfusion medicine, and cellular therapy.
Advertisement
